Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.
about
Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular diseaseAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAsSphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protectionEighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclinProstaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man.Prostacyclin as a potent effector of adipose-cell differentiationProstaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimeticsActivated protein C reduces stress-induced gastric mucosal injury in rats by inhibiting the endothelial cell injuryReceptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled.SerpinC1/Antithrombin III in kidney-related diseasesPlasma prostaglandin E2 concentrations after single dose administration of ketorolac tromethamine (Toradol) in dogsInhibitors of platelet signal transduction as anti-aggregatory drugs.Adventures in vascular biology: a tale of two mediators.The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.Potential therapeutic applications of aspirin and other cyclo-oxygenase inhibitors.Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes.Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.Reduction of death rate due to acute myocardial infarction in subjects with cancers through systemic restoration of impaired nitric oxideMechanism of vascular relaxation by the calcitonin gene-related peptide.Paradoxical fate and biological action of peroxynitrite on human plateletsRegulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications.Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig.The prostanoids in hemostasis and thrombosis: a review.Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.Segregation of discrete GS alpha-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids.12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via Gαs Signaling in PlateletsProstacyclin-dependent activation of adenylate cyclase in a neuronal somatic cell hybrid: prostanoid structure-activity relationshipsInhibition by nicotine of the formation of prostacyclin-like activity in rabbit and human vascular tissue.Desensitization of prostacyclin receptors in a neuronal hybrid cell line.The binding of [3H]-prostacyclin to membranes of a neuronal somatic hybrid.Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass.Role of Ca2+ and cyclic AMP in the regulation of the production of prostacyclin by the vascular endothelium.Release of adenosine from human neutrophils stimulated by platelet activating factor, leukotriene B(4) and opsonized zymosan.Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.Slow-reacting substance of anaphylaxis.Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.Platelets, endothelium-dependent responses and atherosclerosis.Prostacyclin primes pregnant human myometrium for an enhanced contractile response in parturitionProstacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells.
P2860
Q24312335-0BAEB2E8-E294-4660-A7B5-844E1A0BCF98Q27014988-47811522-C0CF-4186-A551-318AD281871EQ28235893-2343C976-0A53-475C-9D47-4FDF6CF77557Q28277612-54F3F4FF-2245-49C9-A621-8E95E72EA6F4Q28319715-662A086D-9598-491D-805D-4E1DB3DDD868Q28342355-C6823FC4-6EEA-4CD9-BEE7-6F8FE182E1AEQ28360502-4248F275-F305-42A6-9748-87024C782404Q28581359-592B42B8-AC6E-414C-8F84-82275B9A8B2AQ33564715-E8CD8C92-E4A6-4C4F-9D51-3EF80E289C1FQ33578786-5C8BC16E-C965-4B7A-BD95-835AEA8C6E03Q33923441-C3BF8B90-33F9-4E31-B6C4-87E4AFF5EFF3Q34232030-B6BFFC3B-E707-4123-918A-737EFFE172C5Q34515584-2F6702A6-AE1A-4CC1-9950-3CEDAFA05213Q34518162-093204DB-6445-43CC-A079-F93B336730DCQ34519530-788ED16D-4B57-4D4F-B902-B7B5CB60C27DQ34790785-262C7818-3146-4808-9FE4-589552EF8729Q35051655-E43350BB-EBC3-4C21-98A8-8E1F33B4A4CFQ35052870-4C674F3F-55B9-4015-AA1B-E36E67ACFBA1Q35099613-0D337535-3D79-4200-91B1-21998062FC58Q35230788-D6BEB38A-ADA8-432D-8F49-E7AA6F31517FQ35592381-DB5BB615-CAA3-4042-AB99-3AF3DCF56D89Q35733494-DB28FB7B-D6F1-4952-A453-22E100C28EACQ35756085-92838903-392B-4524-8A74-540F537FF60CQ35863726-A3309D3E-EA0E-41C5-A88E-E6B2CD9FC7A6Q35871096-75AFB2FA-6BC6-42D1-A1D7-93BE4219DA94Q35887832-14637755-517B-4DB0-9249-EADD7CF759C4Q36089173-5849367F-084B-408E-92F8-27168E676946Q36096728-70A9FFAA-730A-4BB9-8424-82C230B14E12Q36097044-64B6DBDB-B3F2-4DEA-9607-8B05A7A758C7Q36097438-EA787EFD-738E-464C-8D3D-FCAF4C8D7AE6Q36128056-336116C5-B041-4CA0-AE6A-7184C71D9ED1Q36140718-5B6FBE51-C42E-4323-BE49-B1DE08EF28FBQ36277915-59E92C3A-1AF7-47C7-B410-BC862D6D51CBQ36626982-8E945642-FD97-4856-BD5E-64C91168A732Q36705201-AD5587E7-CA9F-416D-8AD6-CFD175B1CBA6Q36801782-EFB5183B-25E4-4336-934B-3C071704E890Q36810953-3BB0D074-1C68-43B9-9BE1-C798DB630E8AQ36845636-4E1A1100-85EE-49EB-A768-755837A1E9CFQ36972755-23C0A717-AAB7-48CA-B4D2-181B84ABFD2EQ36985735-601D5130-815E-4DD4-AE8F-BF832A283251
P2860
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.
@en
type
label
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.
@en
prefLabel
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.
@en
P2093
P1433
P1476
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.
@en
P2093
P304
P356
10.1016/0090-6980(77)90019-3
P577
1977-03-01T00:00:00Z